Medtronic plc (MDT) 13F Ownership Report (Q2 2026)

MDT ranks #121 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

2153 institutions disclose a position in MDT, but none treat it as a major bet — even First Eagle Investment Management, LLC, its most concentrated holder, allocates just 1.8% of its own portfolio to it.

Jane Street Group, LLC has added to its MDT position for two straight quarters, increasing it by $409.3M to reach $657.1M today.

JPMorgan has trimmed its MDT position for two straight quarters, cutting it by $2.9B while still holding $2.3B.

MDT is up 1% today, and institutions have been net buyers of $12.6B this quarter — today's price move and the underlying institutional flow are pointing the same direction.

MDT posted net income of $4.8B over the trailing twelve months, and currently trades at a P/E of 24.7.

• Profitable — net income of $4.8B over the trailing twelve months
• Revenue grew 9.5% year over year
• Net income improved year over year, from $4.3B to $4.8B
• Generated $7.3B in positive operating cash flow
• Current ratio of 2.13x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.87x equity — within a conventional range